Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients

被引:149
作者
Grimm, H
Mertes, N
Goeters, C
Schlotzer, E
Mayer, K
Grimminger, F
Fürst, P
机构
[1] Clin Ctr Passau, Clin Gen Visceral Thorac Vasc & Pediat Surg, D-94032 Passau, Germany
[2] Raphaelsklin, Dept Anaesthesiol & Intens Care, Munster, Germany
[3] Univ Munster, Dept Anaesthesiol & Intens Care, D-4400 Munster, Germany
[4] Fresenius Kabi, Bad Homburg, Germany
[5] Univ Giessen, Dept Internal Med & Intens Care, Giessen, Germany
[6] Univ Bonn, Inst Nutr Sci, D-5300 Bonn, Germany
关键词
lipid emulsion; TPN; fish oil; olive oil; vitamin E; immunomodulation;
D O I
10.1007/s00394-005-0573-8
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 [营养与食品卫生学];
摘要
Objective We assessed the effects of a novel lipid emulsion with reduced content of n-6 fatty acids (FA), increased share of MUFA and n-3 FA and supplemental vitamin E on fatty acid and leukotriene pattern in surgical patients. Methods In a double-blind, randomized study 33 patients received isonitrogenous, isocaloric TPN over 5 postoperative days following major abdominal surgery. 19 patients received the new SMOFlipid(R) 20% and 14 patients a standard soybean oil emulsion (Lipovenoes(R) 20%, both Fresenius Kabi), each 1.5 g fat/kg body weight (BW)/d. Routine lipid biochemistry, plasma tocopherol, fatty acid pattern in plasma phospholipids, as well as leukotriene (LT) release in leukocytes were assessed. Additionally, fatty acid pattern in leukocyte and platelet phospholipids were analysed, but results are not presented. Results On day 6, plasma alpha-tocopherol (34.2 +/- 10.3 vs. 17.6 +/- 2.9 mu mol/L) and, in plasma PL, total n-3 FA were higher (11.1 +/- 1.9 vs. 4.9 +/- 0.9 mol%; p < 0.05) and total n-6 FA lower (23.8 +/- 2.2 vs. 31.8 +/- 1.7 mol%; P < 0.05); the ratio n-3/n-6 FA being elevated (0.5 +/- 0.1 vs. 0.2 +/- 0.0 p < 0.05) with SMOFlipid compared to the soybean oil emulsion. The shares of EPA (3.3 +/- 1.0 vs. 0.4 +/- 0.2 mol%; p < 0.05) and DHA (6.9 +/- 1.8 vs. 3.7 +/- 0.8 mol%; p < 0.05) were highly increased but that of arachidonic acid (AA) was unchanged with SMOFlipid while the ratio EPA/AA was increased (0.7 +/- 0.2 vs. 0.1 +/- 0.0 p < 0.05). LTB5 release was enhanced on day 6 (8.1 +/- 5.3 vs. 1.8 +/- 3.8 pmol/10(7) PMN, p < 0.05) and liberation of LTB4 was lowered, yet not significantly with SMOFlipid (124.0 +/- 51.2 vs. 152.1 +/- 68.8 pmol/10(7) PMN). Length of hospital stay was significantly shorter with SMOFlipid (13.4 +/- 2.0 vs. 20.4 +/- 10.0 days, p < 0.05). Conclusion Treatment with the new emulsion SMOFlipid is well tolerated and modulates FA and leukotriene pattern suggesting favourable anti-inflammatory effects and further clinical benefits.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 38 条
[1]
Adolph M, 2001, CLIN NUTR, V20, P11
[2]
Antebi H, 2004, JPEN J Parenter Enteral Nutr, V28, P142, DOI 10.1177/0148607104028003142
[3]
ARTHAUD JB, 1970, ARCH PATHOL, V90, P433
[4]
BANG HO, 1976, ACTA MED SCAND, V200, P69
[5]
Dietary fat and asthma: Is there a connection? [J].
Black, PN ;
Sharpe, S .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (01) :6-12
[6]
Calder P C, 1998, Curr Opin Clin Nutr Metab Care, V1, P139, DOI 10.1097/00075197-199803000-00001
[7]
N-3 polyunsaturated fatty acids and immune cell function [J].
Calder, PC .
ADVANCES IN ENZYME REGULATION, VOL 37, 1997, 37 :197-237
[8]
POLYUNSATURATED FATTY-ACIDS SUPPRESS HUMAN PERIPHERAL-BLOOD LYMPHOCYTE-PROLIFERATION AND INTERLEUKIN-2 PRODUCTION [J].
CALDER, PC ;
NEWSHOLME, EA .
CLINICAL SCIENCE, 1992, 82 (06) :695-700
[9]
Fatty acids and lymphocyte functions [J].
Calder, PC ;
Yaqoob, P ;
Thies, F ;
Wallace, FA ;
Miles, EA .
BRITISH JOURNAL OF NUTRITION, 2002, 87 :S31-S48
[10]
*DGE, 2004, ERN, P36